Retraction
Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma
Paper Information
Record ID:
34882
Journal:
Publication Date:
October 21, 2014
Retraction Date:
December 21, 2021
(3.9 years years ago)
Subjects:
Institutions:
- Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, 465 Zhongshan Road, Dalian, 116027, Liaoning Province, China
- College of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning Province, China
- Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
IOS Press (bought by Sage November 2023)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3233/TUB-219010Additional Notes:
see also: https://pubpeer.com/publications/C3083F44BC093638DA8C614374F1B4;
Citations (33)
33
Total Citations2
Post-Retraction(6.1%)
31
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
0
After 2+ years
343
Days since retraction (latest)
Statistical Inferences of HIVRNA and Fracture Based on the PAK1 Expression via Neural Network Model
Zheng Yuan, Rui Ma, Qiang Zhang et al. (4 authors)
Current HIV Research
Published: Nov 2022
2 citations
2 citations
343 days after retraction
The Role of AXL Receptor Tyrosine Kinase in Cancer Cell Plasticity and Therapy Resistance
Maria L. Lotsberg, Kjersti Davidsen, Stacey D’mello Peters et al. (7 authors)
Springer eBooks
Published: Jan 2022
11 days after retraction
Ferroptosis as a Potential Cell Death Mechanism against Cisplatin-Resistant Lung Cancer Cell Line
Morteza Golbashirzadeh, Hamid Reza Heidari, Mehdi Talebi et al. (4 authors)
Advanced Pharmaceutical Bulletin
Open Access
Published: Nov 2021
11 citations
11 citations
44 days before retraction
The Profile of MicroRNA Expression and a Group of Genes in Breast Cancer: Relationship to Tumor Progression and Immunohistochemical Status
Е. А. Филиппова, И. В. Пронина, A. M. Burdennyy et al. (6 authors)
Russian Journal of Genetics
Published: Sep 2021
1 citation
1 citation
111 days before retraction
AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer
Wenting Du, Natalie Z. Phinney, Huocong Huang et al. (11 authors)
Molecular Cancer Research
Open Access
Published: Apr 2021
26 citations
26 citations
263 days before retraction
The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications
Martha Wium, Aderonke Ajayi-Smith, Juliano D. Paccez et al. (4 authors)
Cancers
Open Access
Published: Mar 2021
49 citations
49 citations
271 days before retraction
AXL Is a Potential Target for the Treatment of Intestinal Fibrosis
Calen A. Steiner, Eva S. Rodansky, Laura A. Johnson et al. (8 authors)
Inflammatory Bowel Diseases
Open Access
Published: Jul 2020
40 citations
40 citations
522 days before retraction
MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma
Chengyi Jiang, Zhongqiang Cheng, Tao Jiang et al. (5 authors)
Genes & Genomics
Published: Jul 2020
14 citations
14 citations
530 days before retraction
AXL is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Wenting Du, Huocong Huang, Zhaoning Wang et al. (10 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2020
2 citations
2 citations
532 days before retraction
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
Sajid Khan, Samriddhi Shukla, Mohammad Farhan et al. (8 authors)
Life Sciences
Published: Jun 2020
25 citations
25 citations
553 days before retraction
Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells
Atsuo Kurata, Yukako Tachibana, Tadakatsu Takahashi et al. (4 authors)
PLoS ONE
Open Access
Published: Apr 2020
10 citations
10 citations
607 days before retraction
Tumour angiogenesis and c‐Met pathway activation – implications in breast cancer
Suvradeep Mitra, Amanjit Bal, Dharambir Kashyap et al. (7 authors)
Apmis
Published: Jan 2020
17 citations
17 citations
692 days before retraction
AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells
Olivier Zajac, Renaud Leclère, Nicolás André et al. (9 authors)
Cells
Open Access
Published: Jan 2020
32 citations
32 citations
702 days before retraction
Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer
Shinichi Umeda, Mitsuro Kanda, Takashi Miwa et al. (11 authors)
International Journal of Cancer
Open Access
Published: Oct 2019
20 citations
20 citations
804 days before retraction
Ampelopsins A and C Induce Apoptosis and Metastasis through Downregulating AxL, TYRO3, and FYN Expressions in MDA-MB-231 Breast Cancer Cells
Cheng Huang, Yu‐Ling Huang, Chia‐Chi Wang et al. (6 authors)
Journal of Agricultural and Food Chemistry
Published: Feb 2019
16 citations
16 citations
1034 days before retraction
Demethylzeylasteral (T-96) inhibits triple-negative breast cancer invasion by blocking the canonical and non-canonical TGF-β signaling pathways
Liu Li, Ji Yi, Junting Fan et al. (8 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: Feb 2019
25 citations
25 citations
1049 days before retraction
Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
Elisa Holstein, Mathias Binder, Wolfgang Mikulits
International Journal of Molecular Sciences
Open Access
Published: Dec 2018
28 citations
28 citations
1099 days before retraction
The level of synovial AXL expression determines the outcome of inflammatory arthritis, possibly depending on the upstream role of TGF-β1
Claire E. J. Waterborg, Mathijs G A Broeren, E.N. Blaney Davidson et al. (8 authors)
Lara D. Veeken
Published: Oct 2018
19 citations
19 citations
1149 days before retraction
Does Axl have potential as a therapeutic target in pancreatic cancer?
Wenting Du, Rolf A. Brekken
Expert Opinion on Therapeutic Targets
Open Access
Published: Sep 2018
28 citations
28 citations
1184 days before retraction
Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance
Tiina Jokela, Agnete S. T. Engelsen, Agata Rybicka et al. (12 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Apr 2018
25 citations
25 citations
1344 days before retraction
Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
Keisuke Iida, Ryo Sakai, Shota Yokoyama et al. (9 authors)
Scientific Reports
Open Access
Published: Dec 2017
23 citations
23 citations
1469 days before retraction
miR‑21 is involved in transforming growth factor β1‑induced chemoresistance and invasion by targeting PTEN in breast cancer
Xiaomeng Dai, Fang Mao, Shuang Li et al. (6 authors)
Oncology Letters
Open Access
Published: Sep 2017
36 citations
36 citations
1553 days before retraction
MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
Nana Li, Yuan Miao, Yujia Shan et al. (7 authors)
Cell Death and Disease
Open Access
Published: May 2017
182 citations
182 citations
1678 days before retraction
The Role of Axl Receptor Tyrosine Kinase in Tumor Cell Plasticity and Therapy Resistance
Kjersti Davidsen, Gry Haaland, Maria Lie et al. (5 authors)
Springer eBooks
Published: Jan 2017
10 citations
10 citations
1815 days before retraction
Axl and Its Mediated Signaling Axis in Cancer
Giridhar Mudduluru
Springer eBooks
Published: Jan 2017
1 citation
1 citation
1815 days before retraction
Transforming growth factor β as regulator of cancer stemness and metastasis
Claudia Bellomo, Laia Caja, Aristidis Moustakas
British Journal of Cancer
Open Access
Published: Aug 2016
210 citations
210 citations
1951 days before retraction
4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New Axl Kinase Inhibitors
Li Tan, Zhang Zhang, Gao Dong-lin et al. (9 authors)
Journal of Medicinal Chemistry
Published: Jul 2016
50 citations
50 citations
1995 days before retraction
Overexpression of DLX2 is associated with poor prognosis and sorafenib resistance in hepatocellular carcinoma
Jinxia Liu, Xiaopeng Cui, Lishuai Qu et al. (8 authors)
Experimental and Molecular Pathology
Published: Jun 2016
23 citations
23 citations
2016 days before retraction
Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer
Jian Wu, Hongqiang Qin, Ting Li et al. (15 authors)
Oncotarget
Open Access
Published: Mar 2016
39 citations
39 citations
2099 days before retraction
Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway
Lu Gan, Zhu Qiu, Jing Huang et al. (11 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2016
71 citations
71 citations
2181 days before retraction
Peroxisome proliferator-activated receptor-γ agonist troglitazone suppresses transforming growth factor-β1 signalling through miR-92b upregulation-inhibited Axl expression in human keloid fibroblasts in vitro.
Huayu Zhu, Wendong Bai, Jun Li et al. (11 authors)
PubMed
Published: Jan 2016
14 citations
14 citations
2181 days before retraction
The role of TAM receptors in brain tumour cell signalling and behaviour
Mikaella Vouri
Unknown Journal
Published: Jan 2016
2181 days before retraction
Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells
Mikaella Vouri, Qian An, Matthew J. Birt et al. (5 authors)
Oncotarget
Open Access
Published: Apr 2015
46 citations
46 citations
2428 days before retraction
Quick Stats
Total Citations:
33
Years Since Retraction:
3.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025